Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
A major goal of HIV-1 vaccine development is to produce antigens that can induce broadly neutralizing antibodies. Here the authors examine the underlying causes of HIV-1 envelope metastability and design uncleaved, prefusion-optimized gp140 trimers with potential for use as HIV-1 vaccine antigens.
Guardado en:
Autores principales: | Leopold Kong, Linling He, Natalia de Val, Nemil Vora, Charles D. Morris, Parisa Azadnia, Devin Sok, Bin Zhou, Dennis R. Burton, Andrew B. Ward, Ian A. Wilson, Jiang Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3cbbbe8afb93480b992188ff0d705f74 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers
por: Charles D. Morris, et al.
Publicado: (2017) -
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
por: Linling He, et al.
Publicado: (2016) -
Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers
por: Kathrin Koch, et al.
Publicado: (2017) -
Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles
por: Sonu Kumar, et al.
Publicado: (2021) -
Transient opening of trimeric prefusion RSV F proteins
por: Morgan S. A. Gilman, et al.
Publicado: (2019)